Post-Market Registry of Stroke Patients Treated With Medtronic Neurothrombectomy Devices in Southeast Asia: PROSPR-SEA.

ABSTRACT:

Background

Southeast Asia accounts for approximately 10% of stroke-related mortalities worldwide, yet there are limited data regarding mechanical thrombectomy (MT) outcomes in this region. PROSPR-SEA (Post-Market Registry of Stroke Patients Treated With Medtronic Neurothrombectomy Devices to Collect Real-World Data in Southeast Asia) assessed post-market clinical outcomes of MT using the Solitaire Revascularization Device in southeast Asia.

Methods

PROSPR-SEA is a prospective, multicenter, nonrandomized, observational registry of patients who underwent MT using Solitaire as first line treatment at 1 of 10 centers in Vietnam, Thailand, and Singapore between January 2018 and July 2019. The primary end point was functional independence (modified Rankin scale 0-2) at 90 days. Sa

SUBMITTER: Nguyen HT 

PROVIDER: S-EPMC12778723 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature